Churchill Capital X grants options to legal chief

Hall Jason Dean reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Hall Jason Dean reported acquisition or exercise transactions in this Form 4 filing.

Churchill Capital Corp X granted Chief Legal Officer Jason Dean Hall a stock option covering 262,722 shares of common stock. This is a compensatory award rather than an open-market purchase.

According to the award terms, one quarter of the option vests on November 10, 2026. The remaining portion vests in equal monthly installments of 1/48 of the total shares on the same day of each following month, conditioned on Hall’s continued service with the company through each vesting date.

Insider Trade Summary

Grant/Award: 262,722 shares

Grant/Award 1 txn

Insider Hall Jason Dean

Role Chief Legal Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	262,722	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 262,722 contracts (Direct)

Footnotes (1)

1. F1. 1/4th of the shares underlying the option shall vest on November 10, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Churchill Capital Corp X (CCCX) disclose in this Form 4 filing?

Churchill Capital Corp X reported a stock option grant to Chief Legal Officer Jason Dean Hall for 262,722 shares. The award is part of his compensation and is not an open-market transaction, reflecting equity-based incentives tied to continued service with the company.

How many Churchill Capital Corp X (CCCX) shares are covered by Jason Dean Hall’s option?

The option granted to Jason Dean Hall covers 262,722 shares of Churchill Capital Corp X common stock. These shares are not issued immediately; they become exercisable over time as the award vests according to the specified schedule, assuming his continued service with the company.

What is the vesting schedule for Jason Dean Hall’s Churchill Capital Corp X (CCCX) stock option?

One quarter of the option vests on November 10, 2026, for Jason Dean Hall. The remaining three quarters vest in equal monthly installments of 1/48 of the total shares on the same calendar day each month, contingent on his continued service through each vesting date.

Is Jason Dean Hall’s Churchhill Capital Corp X (CCCX) option grant a stock purchase or a compensation award?

The Form 4 describes Jason Dean Hall’s transaction as a grant or award acquisition of a stock option. This indicates a compensation-related equity award granted by the company, rather than an open-market stock purchase made by the executive on a securities exchange.

What role does Jason Dean Hall hold at Churchill Capital Corp X (CCCX) in this Form 4?

Jason Dean Hall is identified as the Chief Legal Officer of Churchill Capital Corp X. The Form 4 reports a stock option grant awarded to him in this capacity, providing equity-based compensation that vests over time with his continued service at the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 08:47 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hall Jason Dean

(Last) (First) (Middle)

C/O INFLEQTION, INC.

1315 WEST CENTURY DRIVE, SUITE 150

(Street)

LOUISVILLE CO 80027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Churchill Capital Corp X/Cayman [ INFQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$13.22	02/13/2026		A		262,722		(1)	02/12/2036	Common Stock	262,722	$0	262,722	D

Explanation of Responses:

1. 1/4th of the shares underlying the option shall vest on November 10, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.

	/s/ Jason D. Hall	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.